RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Labs will become king Research Capital analyst Greg McLeish has upgraded his rating on MediPharm Labs from “Sell” to “Hold” while maintaining his $0.50 price target. Someone should tell hot tech women since she likes analyst predictions. I'm still going to short these guys. Just timing my trade. I agree with the further dilution. They will dilute and then consolidate. Just my opinion.